RBC Capital initiates Arxis stock with Sector Perform rating

RBC Capital initiated coverage on Arxis Inc. (NASDAQ:ARXS) with a Sector Perform rating and a $39 price target, implying modest upside from the $35.10 stock price. The company is highlighted for 48.6% gross margins, $1.59 billion in revenue, $498 million LTM EBITDA, and about 70% exposure to aerospace and defense markets. Arxis also completed a $1.3 billion IPO/reorganization, using $746 million of proceeds to repay term loan borrowings and the remainder for working capital and general corporate purposes.

Analysis

Arxis is being valued like a stable compounder, but the market is still underpricing the optionality embedded in its end-markets and balance-sheet reset. The equity story is less about near-term multiple expansion and more about the company transitioning from a levered, IPO-cleansed industrial to a higher-quality cash converter; that usually creates a 6-12 month window where earnings revisions matter more than headline valuation. If management can convert pricing into actual margin durability, the stock can rerate despite already looking expensive on current-year metrics.

The key second-order effect is that a large A&D exposure makes Arxis a quasi-duration asset on defense capex and aerospace supply-chain normalization. That is attractive if prime contractors keep pushing volume through the chain, but it also means the name is vulnerable to any inventory digestion or program delays that show up with a lag of 2-3 quarters. The post-IPO capital structure improvement helps reduce equity risk, but it also removes some of the leverage that can amplify upside from operational beats, so the next leg likely needs organic growth acceleration rather than just cleaner optics.

Consensus appears to be anchoring on peer-quality valuation and ignoring that the market is paying upfront for an execution path that is not yet fully proven at scale. The more interesting contrarian setup is not to chase the common-stock rerating blindly, but to express bullishness through structures that benefit from gradual multiple compression on the way to higher earnings. If growth stalls while the stock remains above 30x EV/EBITDA, downside can be swift because there is little margin for disappointment.

For competitors, the pressure is on smaller component suppliers with weaker pricing power: if Arxis uses its scale and balance-sheet flexibility to win share, peers with lower margins may be forced into discounting or M&A defense. That creates a potential consolidation wave in the supply chain over the next 12-24 months, which is the clearest path to upside beyond organic growth.

Key Decisions for Investors

• Long ARXS on a 3-6 month horizon only on pullbacks toward support; target a 15-20% upside if the company delivers a clean first few quarters post-IPO, but cut exposure quickly if organic growth decelerates for two consecutive prints.
• Use a call spread in ARXS rather than outright equity: buy 3-6 month calls and sell higher-strike calls to monetize the elevated valuation while preserving upside if the market keeps rewarding defense exposure.
• Pair trade: long ARXS / short a lower-quality industrial component peer with weaker margins and more cyclical end-demand, sized as a relative-quality expression rather than a market beta bet.
• If ARXS rallies hard on multiple expansion without estimate revisions, fade the move with a tactical short or put spread for 1-2 months; the valuation leaves limited room for narrative-only upside.
• Monitor defense and aerospace order data over the next 1-2 quarters; if backlog conversion slows, reduce exposure preemptively because the stock’s downside will likely be driven by revision risk, not macro headlines.